Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=62845862&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO2018007016(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glenmark Pharmaceuticals LtdfiledCriticalGlenmark Pharmaceuticals Ltd
Priority to CONC2018/0007016ApriorityCriticalpatent/CO2018007016A1/en
Publication of CO2018007016A1publicationCriticalpatent/CO2018007016A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La solicitud de patente se refiere a las composiciones farmacéuticas de dosis fijas para administración oral que comprende montelukast o sus sales y levocetirizina o sus sales.The patent application refers to the fixed dose pharmaceutical compositions for oral administration comprising montelukast or its salts and levocetirizine or its salts.
CONC2018/0007016A2018-07-042018-07-04
Pharmaceutical compositions of montelukast and levocetirizine
CO2018007016A1
(en)